---
$id: https://graph.org.ai/products/commodity/51321817
$type: Product
source: UNSPSC
code: "51321817"
title: "Cetaben sodium"
class: "51321800"
classTitle: "Antihyperlipidemic and hypocholesterolemic fibric acids"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cetaben sodium

**UNSPSC Code**: 51321817
**Class**: [Antihyperlipidemic and hypocholesterolemic fibric acids](Antihyperlipidemic and hypocholesterolemic fibric acids.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent with the molecular formula C23H38NO2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 433YPU24B8, chemically known as cl 203,821 but more generally known as cetaben sodium, which bears US NIH Compound Identifier 47262. Most nations, for tariff and trade purposes, schedule cetaben sodium under HS 29224995 and SITC 51465. As of Q4 2014, CETABEN SODIUM remains US FDA's Preferred Term for this commodity. Cetaben sodium bears US NLM identifiers UMLS ID C2347605 and NCI Concept Code C72984. SMILES: CCCCCCCCCCCCCCCCNC1CCC(CC1)C(=O)[O-].[NA+].

